Literature DB >> 30312211

The Impact of Infection and Elevated INR in LVAD-Associated Intracranial Hemorrhage: A Case-Crossover Study.

Sung-Min Cho1, Tiffany Lee2, Randall C Starling3, Nicolas R Thompson2, Ken Uchino2.   

Abstract

Despite the common occurrence left ventricular assist device (LVAD)-associated intracranial hemorrhage, the etiology of intracranial hemorrhage is uncertain. We aim to explore the impact of infection and international normalized ratio (INR) on intracranial hemorrhage in a case-crossover study. We reviewed consecutive patients with intracranial hemorrhage in a prospectively collected data of LVAD patients from a single, tertiary center from October 2004 to December 2016. Information on infection and INR values were collected at the time and 1 month before the intracranial hemorrhage as controls. Of 477 persons with LVAD, 47 (10%) developed intracranial hemorrhage (27 intracerebral, 14 subarachnoid, and 6 subdural hemorrhages). Of 47 (median age 58; 39 males), 27 (54%) persons had active infection at the time of intracranial hemorrhage; seven (21%) of 44 LVADs had infection at 1 month before intracranial hemorrhage. The relative risk of intracranial hemorrhage because of active infection compared with the infections at 1 month was 2.3 (95% CI: 1.5-3.4; p < 0.0001). The mean INRs at the time of intracranial hemorrhage were also significantly higher at the time of hemorrhage compared with those at 1 month (2.6 ± 1.9 vs. 1.8 ± 0.8; p = 0.01). Of 13 persons with cerebral angiogram (seven subarachnoid and six intracerebral hemorrhages), four (57%) infectious intracranial aneurysms were identified only in patients with subarachnoid hemorrhage (SAH) who also had bloodstream infections. Active infection and elevated INR were associated with LVAD-associated intracranial hemorrhage. The occurrence of both bloodstream infection and subarachnoid hemorrhage may indicate the presence of infectious intracranial aneurysm in LVAD.

Entities:  

Mesh:

Year:  2019        PMID: 30312211     DOI: 10.1097/MAT.0000000000000887

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

Review 1.  Neurocritical Care of Mechanical Circulatory Support Devices.

Authors:  Aaron Shoskes; Glenn Whitman; Sung-Min Cho
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-10       Impact factor: 5.081

2.  Hypoxia- and Inflammation-Related Transcription Factor SP3 May Be Involved in Platelet Activation and Inflammation in Intracranial Hemorrhage.

Authors:  Ding Wan; Jin Feng; Peng Wang; Zhenxing Yang; Tao Sun
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

3.  Implications of Causes of Intracranial Hemorrhage During Left Ventricular Assist Device Support.

Authors:  Aaron Shoskes; Catherine Hassett; Aron Gedansky; Randall Carson Starling; Jerry D Estep; Michael Z Y Tong; Sung-Min Cho; Ken Uchino
Journal:  Neurocrit Care       Date:  2022-04-12       Impact factor: 3.532

4.  The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.

Authors:  Zezhong Xiong; Defu Zeng; Shilong Shen; Zhibang Han
Journal:  Comput Math Methods Med       Date:  2022-08-16       Impact factor: 2.809

5.  Characteristics and Outcomes of Left Ventricular-Assist Device-Associated Cerebrovascular Events in Setting of Infectious Intracranial Aneurysms.

Authors:  Tanu Garg; Shyam Panchal; Tariq Nisar; David McCane; Jason Lee; Ken Chyuan Ling; Barry Trachtenberg; Arvind Bhimaraj; David Chiu; Rajan Gadhia
Journal:  Cureus       Date:  2021-05-25

6.  Risk Factors of Ischemic and Hemorrhagic Strokes During Venovenous Extracorporeal Membrane Oxygenation: Analysis of Data From the Extracorporeal Life Support Organization Registry.

Authors:  Sung-Min Cho; Joe Canner; Giorgio Caturegli; Chun Woo Choi; Eric Etchill; Katherine Giuliano; Giovanni Chiarini; Kate Calligy; Peter Rycus; Roberto Lorusso; Bo Soo Kim; Marc Sussman; Jose I Suarez; Romergryko Geocadin; Errol L Bush; Wendy Ziai; Glenn Whitman
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.